Monashee Investment Management LLC Vera Therapeutics, Inc. Transaction History
Monashee Investment Management LLC
- $730 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding VERA
# of Institutions
195Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$118 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$98.5 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$69.2 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$61.3 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$60.5 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $560M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...